Results 181 to 190 of about 17,679 (280)

Divide-and-conquer analysis reveals hidden immune cell influencers across the placenta in preeclampsia. [PDF]

BioData Min
Paik H, Ko TL, Park M, Park JE, Bunis D, Sirota M, Lee BS, Heo HS, Lee SK.   +8 more
europepmc   +1 more source

A fast divide-and-conquer sparse Cox regression. [PDF]

Biostatistics, 2021
Wang Y, Hong C, Palmer N, Di Q, Schwartz J, Kohane I, Cai T.   +6 more
europepmc   +1 more source

Automated Transformation of Sequential Divide-and-Conquer Algorithms into Parallel Programs

, 1995
Divide--and--conquer algorithms obtain the solution to a given problem by dividing it into subproblems, solving these recursively and combining their solutions.
Thilo Kielmann, Bernd Freisleben
core  

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

LHA-YOLO: A Lightweight and High-Accuracy Detector via Parallel Attention and Divide-and-Conquer Fusion for UAV Images. [PDF]

Sensors (Basel)
Yang J, Pan X, Pan Q.
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

deMEM: a novel divide-and-conquer framework based on de Bruijn graph for scalable multiple sequence alignment. [PDF]

Gigascience
Wei Y, Huang Z, Zhang P, Wang Y, Li Y, Yu L, Zou Q.   +6 more
europepmc   +1 more source

A Divide-and-Conquer Bat Algorithm with Direction of Mean Best Position for Optimization of Cutting Parameters in CNC Turnings. [PDF]

Comput Intell Neurosci, 2022
Huang X, He Z, Chen Y, Xie S.
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source